Document is current

Article History

Received: 13 May 2024

Revised: 14 June 2024

Accepted: 23 July 2024

First Online: 30 August 2024

Compliance with ethical standards

:

: The scientific guarantor of this publication is J.S.

: K.J.B., L.M., K.R. and J.T. have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. K.H. is board member (treasurer) of the Dutch Colorectal Cancer Group. C.B. has received grants from Boehringer Ingelheim and Roche; speaker’s honoraria from AbbVie, Janssen, Galapagos, Takeda, and Tillotts. G.D. has served as a consultant for AbbVie, AstraZeneca, Alimentiv, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Cosmo, Eli Lilly, Galapagos, GSK, Johnson and Johnson, Takeda, Pfizer Inc., Polpharma, Prometheus Biosciences, Tillotts and Ventyx; received speaker fees from AbbVie, Boehringer Ingelheim, Celltrion, Eli Lilly, Johnson and Johnson, Takeda, Pfizer Inc. and Tillotts. K.G. has received grants from Pfizer Inc., Celltrion and Galapagos; consultancy fees from AbbVie, Arena Pharmaceuticals, Galapagos, Gilead, Immunic Therapeutics, Janssen Pharmaceuticals, Novartis, Pfizer Inc., Samsung Bioepis and Takeda and speaker’s honoraria from Celltrion, Ferring, Janssen Pharmaceuticals, Novartis, Pfizer Inc., Samsung Bioepis, Takeda and Tillotts. J.S. is the President-elect of the European Society of Gastrointestinal and Abdominal Radiology.

: Dr. Marije Wolvers and Dr. Nahid Montazeri kindly provided methodological and statistical advice for this manuscript.

: Patients agreed on participation with an opt-out procedure according to current local and European guidelines, the Declaration of Helsinki and GCP guidelines.

: Ethical approval was waived by the Medical Ethics Review Committee of the Academic Medical Centre in Amsterdam (The Netherlands).

: Conference presentations: ESGAR Lisbon 2022, ECCO Copenhagen 2023, Dutch Digestive Days (DDD) 2023, DDW Chicago IL 2023, ESGAR Valencia 2023.

: